Detection Limit | Clinical diagnostics, environmental testing | Industry Standard: 1 µM (ISO 17025) Our Base: 0.5 µM (▲) Our Advanced: 0.1 µM (▲▲) | Detects lower MDA levels in diluted samples (e.g., urine). Industry-leading sensitivity for Our Advanced. | Higher costs for advanced kits; requires specialized equipment for sub-µM analysis. |
Assay Time | High-throughput labs, routine screening | Industry Standard: 2h Our Base: 1h (▲) Our Advanced: 30min (▲▲) | Rapid turnaround for time-sensitive research (e.g., acute toxicity studies). | Shorter protocols may compromise accuracy in low-concentration samples. |
Specificity | Drug development, biomarker validation | Industry Standard: 90% cross-reactivity (ASTM E2655) Our Base: 95% (▲) Our Advanced: 99% (▲▲) | Minimizes interference from similar molecules (e.g., lipid peroxidation byproducts). | Advanced kits require pre-treatment steps for non-ideal samples. |
Repeatability | Quality control, longitudinal studies | Industry Standard: CV ≤10% Our Base: CV ≤5% (▲) Our Advanced: CV ≤3% (▲▲) | Consistent results across batches for reproducible research. | Higher precision demands premium reagents, increasing per-test costs. |
Compatibility | Multi-species studies, tissue samples | Industry Standard: 5 sample types Our Base: 10 types (▲) Our Advanced: 15 types (▲▲) | Supports diverse matrices (e.g., plasma, cell lysates, plant extracts). | Expanded compatibility may reduce assay sensitivity for non-optimized samples. |
Safety Compliance | Regulatory-compliant labs | Industry Standard: No certification Our Base: RoHS (▲) Our Advanced: RoHS + ISO 13485 (▲▲) | Ensures no restricted hazardous substances (e.g., lead, cadmium) in reagents. | Advanced kits incur additional certification fees for regulatory bodies. |